Device Industry Has Questions About ‘MedWatch Plus’ Adverse Events System
This article was originally published in The Gray Sheet
Executive Summary
Device trade group AdvaMed is seeking clarity on how FDA's new, all-electronic MedWatch Plus safety information reporting system will relate to the current system, particularly for firms that already submit adverse event reports electronically
You may also be interested in...
CDRH Details Path Forward For National Post-Market Surveillance System
The device center released an updated plan for post-market surveillance reforms, featuring a planning board that will establish a governing structure for the new system, as well as implementation dates for various post-market projects.
GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products
The Government Accountability Office added enhanced oversight of devices, drugs and other medical products to its list of "high-risk" priorities in a report to Congress released Jan. 22
GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products
Recent initiatives hold promise, but “effective implementation” is required to make “meaningful differences,” oversight office says.